Prevalence and Patterns of Antimicrobial Resistance among Escherichia coli and Staphylococcus spp. in a Veterinary University Hospital.
Giorgia CoccaSilvia PivaSara Del MagnoRaffaele ScarpelliniFederica GiacomettiAndrea SerrainoMassimo GiuntiPublished in: Veterinary sciences (2021)
The occurrence of antimicrobial resistance in commensal strains of Escherichia coli and Staphylococcus spp. was investigated in 320 samples collected from patients and the environment of a veterinary university hospital-specifically, the consultation area (CA) and intensive care unit (ICU). E. coli was isolated in 70/160 samples (44%), while Staphylococcus spp. were isolated in 110/160 (69%) samples. The occurrence of multidrug-resistant (MDR) isolates from CA and ICU admission were similar for E. coli (1/12 (8%) versus 4/27 (15%), respectively) and Staphylococcus spp. (10/19 (53%) versus 26/50 (52%), respectively). MDR E. coli isolates increased significantly at hospital discharge (18/31; 58%; p = 0.008). Antimicrobial treatment administered during hospitalization was a risk factor for carriage of MDR E. coli (OR, 23.9; 95% CI: 1.18-484.19; p = 0.04) and MDR Staphylococcus spp. (OR, 19.5; 95% CI 1.30-292.76; p = 0.02), respectively. The odds ratio for MDR E. coli was 41.4 (95% CI 2.13-806.03; p = 0.01), if the administration of fluoroquinolones was evaluated. The mecA gene was detected in 19/24 (79%) coagulase-positive Staphylococcus spp. isolates resistant to oxacillin. High rates of MDR Staphylococcus spp. were reported. Hospitalization in the ICU and antimicrobial treatment were risk factors for colonization by MDR commensal bacteria.
Keyphrases
- escherichia coli
- multidrug resistant
- biofilm formation
- staphylococcus aureus
- antimicrobial resistance
- intensive care unit
- drug resistant
- acinetobacter baumannii
- klebsiella pneumoniae
- gram negative
- mechanical ventilation
- pseudomonas aeruginosa
- risk assessment
- end stage renal disease
- emergency department
- palliative care
- copy number
- prognostic factors
- cystic fibrosis
- mass spectrometry
- smoking cessation
- transcription factor
- genetic diversity
- high speed